7E3 antibody en es it fr

7E3 antibody Brand names, 7E3 antibody Analogs

7E3 antibody Brand Names Mixture

  • No information avaliable

7E3 antibody Chemical_Formula


7E3 antibody RX_link


7E3 antibody fda sheet

7E3_antibody FDA

7E3 antibody msds (material safety sheet)

7E3 antibody Synthesis Reference

(sequence listed in Kohmura C, Gold HK, Yasuda T, Holt R, Nedelman MA, Guerrero JL, Weisman HF, Collen D. A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons.Arterioscler Thromb. 1993 Dec;13(12):1837-42.) patent EP418316

7E3 antibody Molecular Weight


7E3 antibody Melting Point

61 oC (FAB fragment), 71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

7E3 antibody H2O Solubility

No information avaliable

7E3 antibody State


7E3 antibody LogP


7E3 antibody Dosage Forms

Solution (IV Infusion)

7E3 antibody Indication

For treatment of myocardial infarction, adjunct to percutaneous coronory intervention, unstable angina

7E3 antibody Pharmacology

Used for the treatment of myocardial infarction and the prevention of platelet aggregation. Abciximab inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules to GPIIb/IIIa receptor sites on activated platelets.

7E3 antibody Absorption

No information avaliable

7E3 antibody side effects and Toxicity

No information avaliable

7E3 antibody Patient Information

No information avaliable

7E3 antibody Organisms Affected

Humans and other mammals